{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T18:40:21Z","timestamp":1771612821292,"version":"3.50.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"17","license":[{"start":{"date-parts":[[2001,1,1]],"date-time":"2001-01-01T00:00:00Z","timestamp":978307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2001]]},"DOI":"10.1016\/s0959-8049(01)00286-6","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T16:39:58Z","timestamp":1027615198000},"page":"2194-2198","source":"Crossref","is-referenced-by-count":63,"title":["Phase II trial with ISIS 5132 in patients with small-cell (SCLC) and non-small cell (NSCLC) lung cancer. A European Organization for Research and Treatment of Cancer (EORTC) Early Clinical Studies Group report"],"prefix":"10.1016","volume":"37","author":[{"given":"B","family":"Coudert","sequence":"first","affiliation":[]},{"given":"A","family":"Anthoney","sequence":"additional","affiliation":[]},{"given":"W","family":"Fiedler","sequence":"additional","affiliation":[]},{"given":"J.P","family":"Droz","sequence":"additional","affiliation":[]},{"given":"V","family":"Dieras","sequence":"additional","affiliation":[]},{"given":"M","family":"Borner","sequence":"additional","affiliation":[]},{"given":"J.F","family":"Smyth","sequence":"additional","affiliation":[]},{"given":"R","family":"Morant","sequence":"additional","affiliation":[]},{"given":"M.J","family":"de Vries","sequence":"additional","affiliation":[]},{"given":"M","family":"Roelvink","sequence":"additional","affiliation":[]},{"given":"P","family":"Fumoleau","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0959-8049(01)00286-6_BIB1","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1136\/bmj.311.7010.899","article-title":"Chemotherapy in non-small cell lung cancer","volume":"311","year":"1995","journal-title":"Br. Med. J."},{"key":"10.1016\/S0959-8049(01)00286-6_BIB2","unstructured":"DeVore RF III, Johnson DH, Pass HI, et al. In Lung Cancer: Principles and Practice, 2nd edn. Philadelphia, PA, USA, Lippincott Williams & Wilkins, 2000, 924\u2013939."},{"key":"10.1016\/S0959-8049(01)00286-6_BIB3","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/0968-0004(94)90133-3","article-title":"The ins and outs of Raf kinases","volume":"9","author":"Daum","year":"1994","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/S0959-8049(01)00286-6_BIB4","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1128\/MCB.7.3.1171","article-title":"Activation of human raf transforming genes by deletion of normal amino-terminal coding sequences","volume":"7","author":"Stanton","year":"1987","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/S0959-8049(01)00286-6_BIB5","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1073\/pnas.78.2.1181","article-title":"Transforming activity of human tumor DNAs","volume":"78","author":"Krontiris","year":"1981","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0959-8049(01)00286-6_BIB6","first-page":"F21","article-title":"Progress in understanding the molecular pathogenesis of human lung cancer","volume":"19","author":"Sekido","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/S0959-8049(01)00286-6_BIB7","unstructured":"Bos JL. Ras oncogenes in human cancer: a review. Cancer Res. 1989, 49, 4682\u20134689 (published erratum appears in Cancer Res. 1990 50, 1352)."},{"key":"10.1016\/S0959-8049(01)00286-6_BIB8","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1126\/science.7939632","article-title":"Interaction of the protein kinase Raf-1 with 14-3-3 proteins","volume":"266","author":"Fu","year":"1994","journal-title":"Science"},{"key":"10.1016\/S0959-8049(01)00286-6_BIB9","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0378-4274(93)90056-4","article-title":"Oncogene activation","volume":"67","author":"Storm","year":"1993","journal-title":"Toxicol. Lett."},{"key":"10.1016\/S0959-8049(01)00286-6_BIB10","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0092-8674(00)81383-5","article-title":"Bcl-2 targets the protein kinase Raf-1 to mitochondria","volume":"87","author":"Wang","year":"1996","journal-title":"Cell"},{"key":"10.1016\/S0959-8049(01)00286-6_BIB11","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/364249a0","article-title":"Protein kinase C alpha activates RAF-1 by direct phosphorylation","volume":"364","author":"Kolch","year":"1993","journal-title":"Nature"},{"key":"10.1016\/S0959-8049(01)00286-6_BIB12","doi-asserted-by":"crossref","first-page":"15347","DOI":"10.1016\/S0021-9258(18)82262-1","article-title":"A signal transduction pathway for activation of the mdr1 promoter involves the proto-oncogene c-raf kinase","volume":"268","author":"Cornwell","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0959-8049(01)00286-6_BIB13","doi-asserted-by":"crossref","first-page":"15481","DOI":"10.1073\/pnas.93.26.15481","article-title":"Sequence-specific antitumor activity of a phosphorothioate oligodeoxyribonucleotide targeted to human C-raf kinase supports an antisense mechanism of action in vivo","volume":"93","author":"Monia","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0959-8049(01)00286-6_BIB14","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1200\/JCO.1999.17.7.2227","article-title":"Phase I clinical\/pharmacokinetic and pharmacodynamic trial of the c-raf-1 antisense oligonucleotide ISIS 5132 (CGP 69846A)","volume":"17","author":"Stevenson","year":"1999","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/S0959-8049(01)00286-6_BIB15","first-page":"3977","article-title":"c-raf-1 depletion and tumor responses in patients treated with the c-raf-1 antisense oligodeoxynucleotide ISIS 5132 (CGP 69846A)","volume":"5","author":"O'Dwyer","year":"1999","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/S0959-8049(01)00286-6_BIB16","first-page":"1626","article-title":"A phase I trial of c-Raf kinase antisense oligonucleotide ISIS 5132 administered as a continuous intravenous infusion in patients with advanced cancer","volume":"6","author":"Cunningham","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/S0959-8049(01)00286-6_BIB17","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","article-title":"Reporting results of cancer treatment","volume":"47","author":"Miller","year":"1981","journal-title":"Cancer"},{"key":"10.1016\/S0959-8049(01)00286-6_BIB18","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3109\/07357909009017560","article-title":"Comprehensive criteria for assessing therapy-induced toxicity","volume":"8","author":"Ajani","year":"1990","journal-title":"Cancer Invest."},{"key":"10.1016\/S0959-8049(01)00286-6_BIB19","first-page":"1607","article-title":"Antisense approaches enter the clinic","volume":"6","author":"Khuri","year":"2000","journal-title":"Clin. Cancer Res."}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804901002866?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804901002866?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T17:09:51Z","timestamp":1620493791000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804901002866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001]]},"references-count":19,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2001]]}},"alternative-id":["S0959804901002866"],"URL":"https:\/\/doi.org\/10.1016\/s0959-8049(01)00286-6","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2001]]}}}